Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer

Abstract Background Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are diseases of elderly men and are related to increased oxidative stress (OS). Although prolidase has a role in collagen metabolism, it is also used to evaluate OS in many diseases. However, there is a lack of data abo...

Full description

Bibliographic Details
Main Authors: Faruk Kucukdurmaz, Erkan Efe, Ahmet Çelik, Hasan Dagli, Metin Kılınc, Sefa Resim
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Urology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12894-017-0303-6
_version_ 1818932918843604992
author Faruk Kucukdurmaz
Erkan Efe
Ahmet Çelik
Hasan Dagli
Metin Kılınc
Sefa Resim
author_facet Faruk Kucukdurmaz
Erkan Efe
Ahmet Çelik
Hasan Dagli
Metin Kılınc
Sefa Resim
author_sort Faruk Kucukdurmaz
collection DOAJ
description Abstract Background Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are diseases of elderly men and are related to increased oxidative stress (OS). Although prolidase has a role in collagen metabolism, it is also used to evaluate OS in many diseases. However, there is a lack of data about serum prolidase activity (SPA) in prostate cancer. The aim of this study was to evaluate and compare SPA levels in males with BPH and PCa. Methods Evaluation was made of a total of 81 men who underwent transrectal ultrasound guided prostate biopsy for a definitive diagnosis due to high PSA levels. Patients were separated into 2 groups as BPH and PCa patients. Pre-biopsy malondialdehyde (MDA), superoxide dismutase (SOD), PSA levels and serum prolidase activities (SPA) were compared between the groups and the correlations of SPA with the other parameters were also investigated in both groups. Results BPH was diagnosed in 51 patients and PCa in 30. The mean age of patients was similar in both groups as 63.25 ± 5.81 years in the BPH group 65.30 ± 7.35 years in the PCa group(p:0.081). The median MDA and SOD levels were insignificantly increased in the PCa patients. SPA values were similar in BPH and PCa patients. SPA did not correlate with age, PSA, MDA or SOD levels in either group. Conclusions Our study results revealed that serum prolidase activity is similar in BPH and PCa cases and is not correlated with MDA, SOD or PSA levels.
first_indexed 2024-12-20T04:40:07Z
format Article
id doaj.art-c902862ec6bf48bfb6125cfbd0d7fb02
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-12-20T04:40:07Z
publishDate 2017-12-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-c902862ec6bf48bfb6125cfbd0d7fb022022-12-21T19:53:09ZengBMCBMC Urology1471-24902017-12-011711610.1186/s12894-017-0303-6Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancerFaruk Kucukdurmaz0Erkan Efe1Ahmet Çelik2Hasan Dagli3Metin Kılınc4Sefa Resim5Department of Urology, Sutcu Imam University, Avsar KampusuDepartment of Urology, Sutcu Imam University, Avsar KampusuDepartment of Biochemistry, Sutcu Imam UniversityDepartment of Biochemistry, Sutcu Imam UniversityDepartment of Biochemistry, Sutcu Imam UniversityDepartment of Urology, Sutcu Imam University, Avsar KampusuAbstract Background Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are diseases of elderly men and are related to increased oxidative stress (OS). Although prolidase has a role in collagen metabolism, it is also used to evaluate OS in many diseases. However, there is a lack of data about serum prolidase activity (SPA) in prostate cancer. The aim of this study was to evaluate and compare SPA levels in males with BPH and PCa. Methods Evaluation was made of a total of 81 men who underwent transrectal ultrasound guided prostate biopsy for a definitive diagnosis due to high PSA levels. Patients were separated into 2 groups as BPH and PCa patients. Pre-biopsy malondialdehyde (MDA), superoxide dismutase (SOD), PSA levels and serum prolidase activities (SPA) were compared between the groups and the correlations of SPA with the other parameters were also investigated in both groups. Results BPH was diagnosed in 51 patients and PCa in 30. The mean age of patients was similar in both groups as 63.25 ± 5.81 years in the BPH group 65.30 ± 7.35 years in the PCa group(p:0.081). The median MDA and SOD levels were insignificantly increased in the PCa patients. SPA values were similar in BPH and PCa patients. SPA did not correlate with age, PSA, MDA or SOD levels in either group. Conclusions Our study results revealed that serum prolidase activity is similar in BPH and PCa cases and is not correlated with MDA, SOD or PSA levels.http://link.springer.com/article/10.1186/s12894-017-0303-6Prostate cancerBenign prostatic hyperplasiaProlidaseOxidative stress
spellingShingle Faruk Kucukdurmaz
Erkan Efe
Ahmet Çelik
Hasan Dagli
Metin Kılınc
Sefa Resim
Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
BMC Urology
Prostate cancer
Benign prostatic hyperplasia
Prolidase
Oxidative stress
title Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
title_full Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
title_fullStr Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
title_full_unstemmed Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
title_short Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
title_sort evaluation of serum prolidase activity and oxidative stress markers in men with bph and prostate cancer
topic Prostate cancer
Benign prostatic hyperplasia
Prolidase
Oxidative stress
url http://link.springer.com/article/10.1186/s12894-017-0303-6
work_keys_str_mv AT farukkucukdurmaz evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer
AT erkanefe evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer
AT ahmetcelik evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer
AT hasandagli evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer
AT metinkılınc evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer
AT sefaresim evaluationofserumprolidaseactivityandoxidativestressmarkersinmenwithbphandprostatecancer